Clofarabine

Disease Related To Transplantation

Targazyme, Inc.Small moleculePhase 3Dormant

BB

66/ 100

Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence: 54/ 100
Competitive Position: 89/ 100

Competitive context

14 Active assets in the Disease Related To Transplantation cohort.

Asset / Sponsor	Phase	Rating
TACROLIMUS University of Illinois at Chicago	Phase 4	BBB
Cyclosporin A Fernanda P Silveira, MD, MS	Phase 4	BBB
Sirolimus Wyeth is now a wholly owned subsidiary of Pfizer	Phase 4	BBB
BUSULFANUM M.D. Anderson Cancer Center	Phase 3	BB
Fludarabine M.D. Anderson Cancer Center	Phase 3	BB

View all 31 →

Same molecule, other indications

Clofarabine is also rated in:

acute myeloid leukemia with 11q23 abnormalitiesActive

BB

Indicative · Phase 3

70 / 100

acute myeloid leukemia, del(5q31-q32)Dormant

BB

Indicative · Phase 3

70 / 100

acute myeloid leukemia with abnormal bone marrow eosinophils inv(16)(p13q22) or t(16;16)(p13;q22)Dormant

BB

Indicative · Phase 3

70 / 100

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.